Family Psychoeducation Intervention Arm for Paranoia

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Paranoia+5 More
Supporting Patients by Family Education in Psychotic Illness Group - Behavioral
Eligibility
< 65
All Sexes
What conditions do you have?
Select

Study Summary

Background: A lack of education, resources, and support for family carers of young adults with psychotic illnesses leaves them ill-equipped to support their loved one. Although family support groups exist, few groups offer evidence-based, skills-focused, psychoeducation taught by certified professionals and provided on a public-health level. By equipping families with skills and knowledge, public healthcare harnesses a powerful ally to maintain community stabilization. Aims: The primary study goal is to implement a psychoeducation intervention for family carers supporting young adults with psychosis to reduce family burden and foster community stabilization of service users. Methods: A longitudinal pre-post design will be used to assess the long-term effectiveness of the psychoeducation intervention for family carers supporting a young adult with psychosis on service utilization and functional indexes. Nine expert-reviewed, and family peer-informed psychoeducation modules are administered in 2-hour sessions over 9 weeks to family carers. Conclusion: Presenting the novel approach of an expert-reviewed, peer-informed psychoeducation intervention for family carers, with a focus on knowledge and skill development, the researchers contribute to literature and best practice in patient and family-centered care.

Eligible Conditions
  • Paranoia
  • Anosognosia
  • Family Members
  • Psychotic Disorders

Treatment Effectiveness

Study Objectives

11 Primary · 0 Secondary · Reporting Duration: 12-24 months post-intervention

12-24 months post-intervention
Community Appointment Frequency
Crisis Service Frequency
Emergency Department Visit Frequency
Inpatient Admission Frequency
Inpatient Length of Stay
Inpatient Readmission Rate
Justice System Interactions
Resource Intensity Weight (RIW)
24-Month Follow-Up (Post-Intervention)
Family Burden Interview Schedule
Positive and Negative Symptom Schedule
24-Month Follow-Up (Post-Intervention)h
Manchester Short Assessment of Quality of Life

Trial Safety

Trial Design

1 Treatment Group

Family Psychoeducation Intervention Arm
1 of 1
Experimental Treatment

100 Total Participants · 1 Treatment Group

Primary Treatment: Family Psychoeducation Intervention Arm · No Placebo Group · N/A

Family Psychoeducation Intervention Arm
Behavioral
Experimental Group · 1 Intervention: Supporting Patients by Family Education in Psychotic Illness Group · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 12-24 months post-intervention

Who is running the clinical trial?

University of AlbertaLead Sponsor
805 Previous Clinical Trials
369,533 Total Patients Enrolled
Alberta Health servicesOTHER
143 Previous Clinical Trials
305,434 Total Patients Enrolled
Families Supporting Adults with Mental Illness-AlbertaUNKNOWN

Eligibility Criteria

Age < 65 · All Participants · 2 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You are a young adult service user who has had an admission or discharge from an Alberta Health Services or Covenant Health psychiatric unit for psychosis in the Edmonton Zone within previous 12-months.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 23rd, 2021

Last Reviewed: October 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.

References